ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANIP ANI Pharmaceuticals, Inc.

休市中 12-19 16:00:00 EST

82.85

+0.02

+0.02%

盘后83.53

+0.68+0.82%

17:35 EST

最高84.37	最低82.63	成交量96.52万
今开82.87	昨收82.83	日振幅2.11%
总市值18.62亿	流通市值16.88亿	总股本2,247万
成交额8,029万	换手率4.74%	流通股本2,038万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals, Inc.","latestPrice":82.85,"timestamp":1766178000000,"preClose":82.83,"halted":0,"volume":965159,"hourTrading":{"tag":"盘后","latestPrice":83.53,"preClose":82.85,"latestTime":"17:35 EST","volume":188850,"amount":15646911.3069,"timestamp":1766183716719},"delay":0,"floatShares":20380100,"shares":22469032,"eps":-0.649142,"marketStatus":"休市中","change":0.02,"latestTime":"12-19 16:00:00 EST","open":82.87,"high":84.37,"low":82.625,"amount":80285236.11537,"amplitude":0.021067,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.649142,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1064980800000,"exchange":"NASDAQ","adjPreClose":82.83,"postHourTrading":{"tag":"盘后","latestPrice":83.53,"preClose":82.85,"latestTime":"17:35 EST","volume":188850,"amount":15646911.3069,"timestamp":1766183716719},"volumeRatio":2.2205388781066353,"impliedVol":0.4993,"impliedVolPercentile":0.656},"requestUrl":"/m/hq/s/ANIP","defaultTab":"news","newsList":[{"id":"1157372926","title":"ANI Pharmaceuticals 第三季度调整后每股收益 USD 2.04 超过 IBES 预期 USD 1.75","url":"https://stock-news.laohu8.com/highlight/detail?id=1157372926","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157372926?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:08","pubTimestamp":1763572112,"startTime":"0","endTime":"0","summary":"11月7日（路透社） - ANI Pharmaceuticals 第三季度每股收益 USD 1.13。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANIP","LU0566484027.USD","LU1559883803.SGD"],"gpt_icon":0},{"id":"2584101426","title":"Ani Pharmaceuticals, Inc.2025财年第三财季实现净利润24.13百万美元，同比增加199.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584101426","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584101426?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:00","pubTimestamp":1763308813,"startTime":"0","endTime":"0","summary":"11月17日，Ani Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第三财季净利润为24.13百万美元，同比增加199.83%；其中营业收入为2.28亿美元，同比增加54.05%，每股基本收益为1.19美元。从资产负债表来看，Ani Pharmaceuticals, Inc.总负债9.02亿美元，其中短期债务15.24百万美元，资产负债比为1.57，流动比率为2.58。机构评级：截至2025年11月17日，当前有8家机构对Ani Pharmaceuticals, Inc.目标价做出预测，其中目标均价为109.88美元，其中最低目标价为90.00美元，最高目标价为121.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000026a4a5a8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000026a4a5a8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0566484027.USD","LU1559883803.SGD","ANIP"],"gpt_icon":0},{"id":"1138996102","title":"异动解读 | ANI制药第三季度业绩超预期并上调全年指引，股价盘中大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138996102","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138996102?lang=zh_cn&edition=full","pubTime":"2025-11-07 23:34","pubTimestamp":1762529695,"startTime":"0","endTime":"0","summary":"周五盘中，ANI制药股价大幅上涨5.29%，引发市场关注。这一显著涨幅主要源于公司发布的强劲财报和乐观展望。根据公司公布的最新财务报告，ANI制药第三季度业绩表现出色，超出市场预期。更令投资者振奋的是，ANI制药上调了2025财年的收入指引。截至上一交易日，公司股价已累计上涨63.2%。这次财报超预期和上调全年指引进一步增强了投资者对公司未来发展的信心，推动股价在当日交易中大幅上扬。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"1139733017","title":"异动解读 | ANI制药业绩超预期并上调全年指引，股价盘中大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139733017","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139733017?lang=zh_cn&edition=full","pubTime":"2025-11-07 23:34","pubTimestamp":1762529675,"startTime":"0","endTime":"0","summary":"周五盘中，ANI制药股价大幅上涨5.29%，引发市场关注。这一显著涨幅主要源于公司发布的强劲第三季度财报以及上调的全年收入预期。根据公司公布的财务报告，ANI制药第三季度业绩表现亮眼。更值得注意的是，ANI制药上调了2025财年的收入指引。这一调整显示出管理层对公司未来业绩增长的信心，也是推动股价上涨的重要因素。分析师们普遍认为，这一上调后的指引仍具有一定的保守性，可能为未来的正面惊喜留下空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"1119699483","title":"ANI Pharmaceuticals公布新Day临床试验结果，将在2025年美国眼科学会会议上进行最新口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1119699483","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119699483?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:51","pubTimestamp":1760611869,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals公布新Day临床试验结果，将在2025年美国眼科学会会议上进行最新口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","LU1559883803.SGD","BK4007","ANIP"],"gpt_icon":0},{"id":"1150220850","title":"异动解读 | 业绩超预期，ANI制药盘中大涨16.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150220850","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150220850?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:00","pubTimestamp":1754661655,"startTime":"0","endTime":"0","summary":"周五盘中，ANI制药股价大涨16.95%，引起市场广泛关注。这一显著涨幅主要源于该公司公布的最新季度财报远超分析师预期。根据ANI制药发布的财报，截至3月31日的季度调整后每股收益达到1.80美元，大幅超越分析师平均预期的1.42美元，同时也高于去年同期的1.21美元。值得注意的是，华尔街分析师对ANI制药的前景持积极态度。目前，分析师对该公司股票的平均评级为\"买入\"，12个月目标价中位数为84.00美元，较上一交易日收盘价高出约17.8%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"2517948685","title":"Guggenheim：维持ANI Pharmaceuticals(ANIP.US)评级，由买入调整至买入评级, 目标价由84.00美元调整至86.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948685","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948685?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185815,"startTime":"0","endTime":"0","summary":"Guggenheim：维持ANI Pharmaceuticals(ANIP.US)评级，由买入调整至买入评级, 目标价由84.00美元调整至86.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05224348547985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ANIP"],"gpt_icon":0},{"id":"1193043680","title":"异动解读 | 财报业绩超预期,ANI制药盘中大涨14.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193043680","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193043680?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:45","pubTimestamp":1740753917,"startTime":"0","endTime":"0","summary":"ANI制药公司(ANIP)今日盘中股价大涨14.73%,成为市场关注的焦点。\n\n公司此前发布的2024年第四季度财报显示,其调整后每股收益为1.63美元,高于分析师普遍预期的1.44美元;营收达到1.9057亿美元,同样超出1.7537亿美元的预期水平。主因是公司两款罕见病药物Iluvien和Yutiq销售表现亮眼。\n\n另外,公司预计2025年全年调整后每股收益将达到6.12-6.49美元的区间,高于当前市场预期5.56美元的水平。在此业绩表现支撑下,安纳吉资本给予ANI股票\"买入\"评级,12个月目标价中位数达到80美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"1151632074","title":"ANI制药公司预计2025年调整后每股收益为6.12美元至6.49美元，而市场预期为5.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151632074","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151632074?lang=zh_cn&edition=full","pubTime":"2025-02-28 20:04","pubTimestamp":1740744262,"startTime":"0","endTime":"0","summary":"ANI制药公司预计，2025年调整后每股收益将在6.12美元至6.49美元之间，而市场预期为5.56美元。以上内容来自Benzinga Earnings专栏，原文如下：ANI Pharmaceuticals Expects 2025 Adjusted EPS Of $6.12-$6.49 Versus Consensus Of $5.56","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"1156054280","title":"异动解读 | 公司财报超预期,ANIP制药股盘前大涨8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156054280","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156054280?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:56","pubTimestamp":1740743778,"startTime":"0","endTime":"0","summary":"周五盘前交易中,ANIP制药公司(NASDAQ:ANIP)股价大涨8.08%,引起了市场广泛关注。这一大涨很可能是由于公司2024年第四季度财报表现优异所致。\n\n根据最新财报显示,ANIP第四季度调整后每股收益为1.63美元,超过分析师平均预期的1.44美元,同比增长63%。公司第四季度销售额达到1.9057亿美元,也超出分析师预期的1.7537亿美元,同比增长44.75%。\n\n财报表现出色使市场对ANIP制药公司未来发展前景更加看好,成为当前公司股价大涨的主要驱动力。不过该公司下一季度和全年的表现还有待进一步关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0},{"id":"1113236856","title":"ANI制药公司2024年第四季度调整后每股收益$1.63 超过预期的$1.44，销售额$1.9057亿超过预期的$1.7537亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1113236856","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113236856?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:54","pubTimestamp":1740743662,"startTime":"0","endTime":"0","summary":"公司报告季度销售额为$1.9057亿，超过分析师一致预期的$1.7537亿，超出预期8.67%。这比去年同期的销售额$1.3165亿增长了44.75%。以上内容来自Benzinga Earnings专栏，原文如下：ANI Pharmaceuticals  reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.44 by 13.19 percent. This is a 63 percent increase over earnings of $1.00 per share from the same period last year.  The company reported quarterly sales of $190.57 million which beat the analyst consensus estimate of $175.37 million by 8.67 percent.  This is a 44.75 percent i","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ANI制药公司2024年第四季度调整后每股收益$1.63 超过预期的$1.44，销售额$1.9057亿超过预期的$1.7537亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP"],"gpt_icon":0},{"id":"2503626317","title":"Ani Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%报56.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503626317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503626317?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:38","pubTimestamp":1736955510,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时38分，Ani Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报56.87美元/股，成交量3.5874万股，换手率0.17%，振幅3.82%。Ani Pharmaceuticals, Inc.股票所在的制药行业中，整体涨幅为0.53%。其相关个股中，Cbdmd, Inc.、Therapeuticsmd, Inc.、Journey Medical Corporation涨幅较大，Cbdmd, Inc.、大自然药业、Akanda Corp.较为活跃，换手率分别为58.79%、18.72%、4.77%，振幅较大的相关个股有Cbdmd, Inc.、Talphera, Inc.、Petros Pharmaceuticals, Inc.，振幅分别为28.40%、11.88%、10.50%。Ani Pharmaceuticals, Inc.公司简介：ANI Pharmaceuticals Inc 开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152338309604c655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152338309604c655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ANIP"],"gpt_icon":0},{"id":"1193537946","title":"异动解读 | ANI制药业绩超预期 股价盘前大涨8.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193537946","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193537946?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:24","pubTimestamp":1731083090,"startTime":"0","endTime":"0","summary":"在2024年11月8日盘前交易中,ANI Pharmaceuticals股价大涨8.77%,引发市场广泛关注。导致该公司股价大涨的主要原因是其第三季度财报数据超出华尔街分析师预期。具体来看,ANI制药在截至2024年9月30日的第三季度公布了亮眼的财务业绩。营收方面,ANI公司季度营收为1.4833亿美元,同比增长12.5%,也超出了分析师预期的1.4435亿美元。ANI制药优异的季度业绩受到了分析师界的积极评价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANIP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.0306},{"period":"1month","weight":0.0314},{"period":"3month","weight":-0.144},{"period":"6month","weight":0.2637},{"period":"1year","weight":0.5269},{"period":"ytd","weight":0.4987}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ANI Pharmaceuticals, Inc.于2001年4月成立于特拉华州。该公司是一家综合性的特种制药公司，致力于通过开发，制造和销售高质量的品牌和通用处方药来为公司的客户提供价值。 该公司专注于利基和高入口机会，包括受控物质，抗癌（溶瘤药），激素和类固醇，以及复杂的制剂。 该公司位于明尼苏达州Baudette的两家制药厂能够生产口服固体剂量产品，以及液体和局部，受控物质和必须在完全封闭的环境中制造的有效产品。 该公司的战略是使用其资产开发，收购，制造和销售品牌和通用专业处方药。","yearOnYearQuotes":[{"month":1,"riseRate":0.68,"avgChangeRate":0.064504},{"month":2,"riseRate":0.44,"avgChangeRate":0.015273},{"month":3,"riseRate":0.4,"avgChangeRate":-0.024868},{"month":4,"riseRate":0.56,"avgChangeRate":0.134707},{"month":5,"riseRate":0.4,"avgChangeRate":-0.025383},{"month":6,"riseRate":0.653846,"avgChangeRate":0.039424},{"month":7,"riseRate":0.423077,"avgChangeRate":-0.036377},{"month":8,"riseRate":0.461538,"avgChangeRate":0.008153},{"month":9,"riseRate":0.423077,"avgChangeRate":0.022238},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.034116},{"month":11,"riseRate":0.576923,"avgChangeRate":0.07966},{"month":12,"riseRate":0.423077,"avgChangeRate":-0.05201}],"exchange":"NASDAQ","name":"ANI Pharmaceuticals, Inc.","nameEN":"ANI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ANI Pharmaceuticals, Inc.,ANIP,ANI Pharmaceuticals, Inc.股票,ANI Pharmaceuticals, Inc.股票老虎,ANI Pharmaceuticals, Inc.股票老虎国际,ANI Pharmaceuticals, Inc.行情,ANI Pharmaceuticals, Inc.股票行情,ANI Pharmaceuticals, Inc.股价,ANI Pharmaceuticals, Inc.股市,ANI Pharmaceuticals, Inc.股票价格,ANI Pharmaceuticals, Inc.股票交易,ANI Pharmaceuticals, Inc.股票购买,ANI Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}